You may also like
Blood Component Recalls and Market Withdrawals: Frequency, Reasons, and Management in the United States
The U.S. Food and Drug Administration has issued several recent guidances that address transfusion service actions for dealing with specific infectious disease problems. This present article updates our 2004 recommendations as to when to notify physicians about transfused nonconforming blood components.
1 min read
Heart Failure Patients with Preserved Left Ventricular Systolic Function Have 5-Year Mortality Rate of 25%
Patients with clinical heart failure who also have impaired left ventricular systolic function have a significantly greater mortality risk than those with […]
1 min read
Intraoperative Cell Saving: Is the Solution the Actual Problem?
Washing residual cardiopulmonary bypass pump blood with Balsol solution results in a resuspended red cell concentrate with a superior electrolyte profile and a strong ion difference similar to that of residual pump blood.
1 min read